192 related articles for article (PubMed ID: 36142647)
1. Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice.
Seidel F; Kleemann R; van Duyvenvoorde W; van Trigt N; Keijzer N; van der Kooij S; van Kooten C; Verschuren L; Menke A; Kiliaan AJ; Winter J; Hughes TR; Morgan BP; Baas F; Fluiter K; Morrison MC
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142647
[TBL] [Abstract][Full Text] [Related]
2. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.
van den Hoek AM; de Jong JCBC; Worms N; van Nieuwkoop A; Voskuilen M; Menke AL; Lek S; Caspers MPM; Verschuren L; Kleemann R
Metabolism; 2021 Nov; 124():154873. PubMed ID: 34478753
[TBL] [Abstract][Full Text] [Related]
3. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
van den Hoek AM; Verschuren L; Worms N; van Nieuwkoop A; de Ruiter C; Attema J; Menke AL; Caspers MPM; Radhakrishnan S; Salic K; Kleemann R
Cells; 2020 Sep; 9(9):. PubMed ID: 32883049
[TBL] [Abstract][Full Text] [Related]
4. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lütjohann D; Staels B; Hofker MH; Shiri-Sverdlov R
PLoS One; 2012; 7(1):e30668. PubMed ID: 22295101
[TBL] [Abstract][Full Text] [Related]
5. Cellular cholesterol accumulation modulates high fat high sucrose (HFHS) diet-induced ER stress and hepatic inflammasome activation in the development of non-alcoholic steatohepatitis.
Bashiri A; Nesan D; Tavallaee G; Sue-Chue-Lam I; Chien K; Maguire GF; Naples M; Zhang J; Magomedova L; Adeli K; Cummins CL; Ng DS
Biochim Biophys Acta; 2016 Jul; 1861(7):594-605. PubMed ID: 27090939
[TBL] [Abstract][Full Text] [Related]
6. Heat-Inactivated
Morrison MC; Gart E; Duyvenvoorde WV; Snabel J; Nielsen MJ; Leeming DJ; Menke A; Kleemann R
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216439
[TBL] [Abstract][Full Text] [Related]
7. Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibody.
Seidel F; Fluiter K; Kleemann R; Worms N; van Nieuwkoop A; Caspers MPM; Grigoriadis N; Kiliaan AJ; Baas F; Michailidou I; Morrison MC
Front Cell Neurosci; 2023; 17():1205261. PubMed ID: 37457817
[TBL] [Abstract][Full Text] [Related]
8. Aucubin administration suppresses STING signaling and mitigated high-fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Liu Y; Zhang Y; Zhu H; Shen W; Chen Z; Bai J; Shuang T; Chen Q
Food Chem Toxicol; 2022 Nov; 169():113422. PubMed ID: 36108984
[TBL] [Abstract][Full Text] [Related]
9. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
Lytle KA; Wong CP; Jump DB
PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
[TBL] [Abstract][Full Text] [Related]
10. Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-/-.Leiden mice.
Morrison MC; Mulder P; Salic K; Verheij J; Liang W; van Duyvenvoorde W; Menke A; Kooistra T; Kleemann R; Wielinga PY
Int J Obes (Lond); 2016 Sep; 40(9):1416-23. PubMed ID: 27121255
[TBL] [Abstract][Full Text] [Related]
11. A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-/-.Leiden mice.
Schoemaker MH; Kleemann R; Morrison MC; Verheij J; Salic K; van Tol EAF; Kooistra T; Wielinga PY
PLoS One; 2017; 12(7):e0180648. PubMed ID: 28678821
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine.
Mueller AM; Kleemann R; Gart E; van Duyvenvoorde W; Verschuren L; Caspers M; Menke A; Krömmelbein N; Salic K; Burmeister Y; Seilheimer B; Morrison MC
Front Endocrinol (Lausanne); 2021; 12():601160. PubMed ID: 33815271
[TBL] [Abstract][Full Text] [Related]
13. Pathways linking aging and atheroprotection in Mif-deficient atherosclerotic mice.
Krammer C; Yang B; Reichl S; Besson-Girard S; Ji H; Bolini V; Schulte C; Noels H; Schlepckow K; Jocher G; Werner G; Willem M; El Bounkari O; Kapurniotu A; Gokce O; Weber C; Mohanta S; Bernhagen J
FASEB J; 2023 Mar; 37(3):e22752. PubMed ID: 36794636
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice.
Rensen SS; Bieghs V; Xanthoulea S; Arfianti E; Bakker JA; Shiri-Sverdlov R; Hofker MH; Greve JW; Buurman WA
PLoS One; 2012; 7(12):e52411. PubMed ID: 23285030
[TBL] [Abstract][Full Text] [Related]
15. RAGE deficiency does not affect non-alcoholic steatohepatitis and atherosclerosis in Western type diet-fed Ldlr
Bijnen M; Beelen N; Wetzels S; Gaar JV; Vroomen M; Wijnands E; Scheijen JL; van de Waarenburg MPH; Gijbels MJ; Cleutjens JP; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K
Sci Rep; 2018 Oct; 8(1):15256. PubMed ID: 30323247
[TBL] [Abstract][Full Text] [Related]
16. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
[TBL] [Abstract][Full Text] [Related]
17. The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis.
Mulder P; van den Hoek AM; Kleemann R
PLoS One; 2017; 12(1):e0169740. PubMed ID: 28076416
[TBL] [Abstract][Full Text] [Related]
18. STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia.
Cansby E; Magnusson E; Nuñez-Durán E; Amrutkar M; Pedrelli M; Parini P; Hoffmann J; Ståhlman M; Howell BW; Marschall HU; Borén J; Mahlapuu M
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1723-1737. PubMed ID: 29930001
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
20. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
